AROA BIOSURGERY LIMITED — Director's Dealing 2025

Jul 24, 2025

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Aroa Biosurgery Limited
ARBN	638 867 473

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Phillip McCaw
Date of last notice	23 February 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Phil McCaw (Beneficiary) Phillip John McCaw & Anne Elizabeth Forsyth (Beneficiary) Horizon Two Adventures Trust FTL Trustees (McSyth) Limited> (Beneficiary)
Date of change	23 July 2025

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	Direct 172,620 Options exercisable at $1.083 expiring 29 February 2028 Indirect McSyth Capital Investment Trust of which he is a trustee and beneficiary 19,597,251 Fully Paid Ordinary Shares 81,925 Options exercisable at $0.75 expiring 23 July 2025 McSyth Charitable A/C of which he is a trustee and beneficiary 153,903 Fully Paid Ordinary Shares Horizon Two Adventures Trust _FTL Trustees (McSyth) Limited> of which he is a trustee and beneficiary 326,000 Fully Paid Ordinary Shares
Class	Options exercisable at $0.75 expiring 23 July 2025
Number acquired	Nil
Number disposed	81,925
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil
No. of securities held after change	Direct 172,620 Options exercisable at $1.083 expiring 29 February 2028 Indirect McSyth Capital Investment Trust of which he is a trustee and beneficiary 19,597,251 Fully Paid Ordinary Shares McSyth Charitable A/C of which he is a trustee and beneficiary 153,903 Fully Paid Ordinary Shares Horizon Two Adventures Trust _FTL Trustees (McSyth) Limited> of which he is a trustee and beneficiary 326,000 Fully Paid Ordinary Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	Lapse due to expiry of options

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3